ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 217 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16 | -100.0% | 1 | -100.0% | 0.00% | -100.0% |
| Q4 2021 | $13,536,000 | +377.5% | 579,961 | +239.8% | 0.05% | +360.0% |
| Q3 2021 | $2,835,000 | +887.8% | 170,661 | +1350.6% | 0.01% | +900.0% |
| Q2 2021 | $287,000 | -96.8% | 11,765 | -93.1% | 0.00% | -97.0% |
| Q4 2020 | $9,101,000 | +2538.0% | 170,240 | +654.4% | 0.03% | +1550.0% |
| Q2 2018 | $345,000 | -8.2% | 22,565 | +80.7% | 0.00% | -33.3% |
| Q4 2017 | $376,000 | -70.3% | 12,489 | -62.8% | 0.00% | -75.0% |
| Q3 2017 | $1,266,000 | – | 33,602 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |